Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Transl Res. 2016 Mar 31;175:103–115.e4. doi: 10.1016/j.trsl.2016.03.017

Table 4. Multiple Regression Analysis of NRM at Day 100, Months 6 and 12 with Predicted F-ara-A AUCpred in the Independent Cohort.

Parameter Hazard Ratio (95% CI) at 100 days p-value Hazard Ratio (95% CI) at 6 months P value Hazard Ratio (95% CI) at 12 months p-value
F-ara-A AUCpred
<6.00 (μg*hr/mL) 1.00 1.00 1.00
≥6.00 (μg*hr/mL) 5.30 (1.59-17.7) 0.01 2.42 (0.87-6.77) 0.09 2.67 (1.31-5.43) 0.01
Donor source
Related 1.00 1.00 1.00
Unrelated (UR) 4.32 (1.16-16.06) 0.03 2.79 (1.06-7.31) 0.04 3.35 (1.59-7.05) <0.01
UR cord blood 1.91 (0.55-6.67) 0.31 1.71 (0.70-4.13) 0.24 1.33 (0.61-2.86) 0.47
Disease risk
Standard 1.00 1.00
High 2.84 (0.87-9.33) 0.08 2.27 (0.91-5.65) 0.08 NA NA
Comorbidity score
0 1 1 1
1-2 2.27 (0.72-7.13) 0.16 2.42 (1.04-5.62) 0.04 1.93 (0.93-4.01) 0.08
≥3 2.83 (0.83-9.57) 0.10 1.72 (0.66-4.48) 0.27 1.80 (0.88-3.68) 0.11
Acute GVHD (grades II-IV) before NRM
No 1.00 1.00 1.00
Yes 1.89 (0.71-5.00) 0.20 2.35 (1.07-5.15) 0.03 3.04 (1.62-5.73) <0.01

NA is not applicable and indicates that the covariate was not significant in the multivariate full model (p >0.20) and was eliminated in the final reduced model.